Wednesday, January 28, 2026

Shaping the Future: Heidi Lüttgens Takes Over the Management of Psyma+Exevia

With a well-planned and forward-looking leadership transition, Psyma+Exevia Health GmbH is restructuring its management team. Former Managing Directors Norbert Schell and Roland Herterich are handing over operational responsibility to Heidi Lüttgens, thereby ensuring the company’s long-term development.

The transition stands for both continuity and renewal. With more than 30 employees, Psyma+Exevia is well positioned and has an established business model in the healthcare and market research environment. “We are handing over a strong company into reliable hands,” emphasizes Norbert Schell. Heidi Lüttgens brings not only deep professional expertise but also a strong drive to strategically advance the company.

Roland Herterich also highlights the careful preparation of the succession: “Our values, quality, and customer proximity remain – while at the same time we are setting new impulses for growth and innovation.” This ensures that the successful work of recent years will be consistently continued while being further developed with a future-oriented mindset.

Heidi Lüttgens brings many years of experience in industry and research institutes. In her new role, she is placing a clear focus on expanding the service portfolio and on the targeted use of modern technologies. “We preserve what makes us strong and enhance it with forward-looking building blocks – from new services to AI-supported tools,” she explains. The goal is to remain a reliable partner for clients while proactively addressing the requirements of tomorrow.

With this generational change in management, Psyma+Exevia strengthens stability and reliability while gaining additional momentum. The structured transition creates a solid foundation to leverage market opportunities and sustainably enhance the company’s performance.